Advertisement
Screener

PHARMA-BIO SERV, INC. (PBSV) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

1.8 / 5 stars · 30/82 Roast Me

PHARMA-BIO SERV, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

PHARMA-BIO SERV, INC. (PBSV) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 61.80% for the 12-month period ending 2015-10-31, per its 10-K filed 2016-01-29.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2016-01-29

  • PHARMA-BIO SERV, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2015 was 61.80%, a 13.19% increase from fiscal 2014.
  • PHARMA-BIO SERV, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2014 was 54.60%, a 14.47% increase from fiscal 2013.
  • PHARMA-BIO SERV, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2013 was 47.70%, a 16.63% increase from fiscal 2012.
  • PHARMA-BIO SERV, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2012 was 40.90%, a 44.95% decline from fiscal 2011.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month
2015-10-3161.80%
10-K · filed 2016-01-29
2014-10-3154.60%
10-K · filed 2016-01-29
2013-10-3147.70%
10-K · filed 2015-01-29
2012-10-3140.90%
10-K · filed 2014-01-29
2011-10-3174.30%
10-K · filed 2013-01-29